By stimulating GLP-1 receptors on vagal afferents in the gut, it physically slows down how fast food leaves your stomach
Maintenance Dose: The Tirzepatide maintenance dose depends on individual weight loss and glucose control goals
Common requirements include: BMI of 30 or higher (obesity) BMI of 27 or higher with at least one weight-related health condition, such as: Type 2 diabetes High blood pressure High cholesterol Sleep apnea If you meet either of these criteria, you may qualify for insurance coverage for GLP-1/GIP medications
is supported by the FNR-ATTRACT (A14/BM/7632103) and the FNR-CORE (C21/BM/15796788) programs
This page is general in nature, is not medical advice, and does not make therapeutic claims
When you're trying to answer a difficult, often moving-target objective, you must have confidence in your tools